Raptor Pharmaceutical Announces Proposed Public Offering of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Raptor Pharmaceutical Announces Proposed Public Offering of Common Stock

NOVATO, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP ), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock. In addition, the company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional 15 percent of the number of shares of common stock sold in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares are being offered by the company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.

Citigroup, Leerink Partners and Cowen and Company are acting as lead joint book-running managers for the offering. JMP Securities is acting as lead manager and Janney Montgomery Scott LLC is acting as a co-manager for the offering.

A registration statement relating to these securities was filed with the Securities and Exchange Commission (SEC) and became automatically effective on March 30, 2015. This offering is being made solely by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus related to the offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov . Copies of the preliminary prospectus supplement and accompanying prospectus related to the offering may also be obtained from Citigroup Global Markets Inc., Attention: c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, New York, 11717, or by phone at (800) 831-9146, or by email at prospectus@citi.com ; or from the offices of Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, Massachusetts 02110, or by phone at (800) 808-7525, or by email at syndicate@leerink.com .

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor will there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or other jurisdiction.

About Raptor Pharmaceutical

Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases. The company is engaged in multiple therapeutic areas such as nephropathic cystinosis, Huntington's disease (HD), nonalcoholic steatohepatitis (NASH), and Leigh syndrome and other mitochondrial diseases. With an approved product in the U.S. and EU, Raptor also holds several orphan drug designations, including exclusivity for nephropathic cystinosis in the U.S. and EU, and orphan drug designation for HD in the U.S. and EU.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the anticipated public offering, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause our actual results to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties related to market conditions, the completion of the public offering on the anticipated terms or at all, the final terms of the proposed offering, and the satisfaction of customary closing conditions related to the proposed public offering, among others. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the Company in general, see Raptor's Registration Statement on Form S-3 filed with the SEC on March 30, 2015, as may be amended from time to time, together with its preliminary prospectus supplement relating to the proposed offering to be filed with the SEC, and the documents incorporated by reference therein, including its Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 2, 2015, and its subsequent periodic reports filed with the SEC, including under the caption "Risk Factors". Raptor undertakes no obligation to update or revise any forward-looking statements.

COMPANY CONTACT: Kimberly Lee, D.O. Vice President, Corporate Strategy and Communications Raptor Pharmaceutical Corp. (415) 408-6351 INVESTOR CONTACT: Westwicke Partners, LLC Robert H. Uhl Managing Director (858) 356-5932 MEDIA CONTACT: Cammy Duong Canale Communications (619) 849-5382

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 83

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 144

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 381

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Alert: Class Action Lawsuit Against Elanco Animal Health

Updated Category News Views 133

Class Action Lawsuit Filed Against Elanco Animal Health Elanco Animal Health Incorporated has come under scrutiny following a recently filed class action lawsuit. This legal action is notable as it seeks accountability on behalf of shareholders who acquired Elanco securities during a specified period. The lawsuit targets Elanco, pointing to serious allegations regarding...

Continue Reading
Xinjiang's Growth: A Bright Future Awaits Under New Strategies

Updated Category News Views 423

Xinjiang's Economic Evolution: A Time of Prosperity Xinjiang is currently witnessing an era of unparalleled growth and development. As highlighted in a recent white paper issued by the Information Office of the State Council, this region has embarked on a transformative journey. The focus on lawful governance, cultural integration, and economic fortification promises a...

Continue Reading
Google's Pixel 10 Launch: A Direct Challenge to Apple

Updated Category News Views 301

Google Takes a Jab at Apple During Pixel 10 Unveiling In an intriguing twist to the smartphone rivalry, Alphabet Inc.'s Google showcased its latest innovations, the Pixel 10 and Pixel Watch 4, during the 'Made By Google 2025' event. This occasion wasn't just about flaunting new hardware; it was also a platform for Google to subtly criticize Apple Inc. and its recent...

Continue Reading
Celebrate National Ice Cream Day with Kilwins' Sweet Giveaway

Updated Category News Views 211

Sweet Celebrations at Kilwins During the joyous occasion of National Ice Cream Day, Kilwins, a beloved name in hand-crafted chocolates, fudge, and super-premium ice cream, has exciting plans for ice cream enthusiasts. The celebration includes a delightful Instagram sweepstakes where participants can win 'Free Ice Cream for a Year.' This fun contest invites fans to engage...

Continue Reading
Empowering the Future of Bitcoin Mining with SUP Miner

Updated Category News Views 225

Harnessing Cloud Mining with SUP Miner As the world of cryptocurrency mining becomes more intricate and expensive, SUP Miner provides a reliable and cost-effective solution, catering to both novices and seasoned crypto investors. The Evolution into Cloud Mining With the growing complexity of cryptocurrency mining, traditional mining methods, which once relied on...

Continue Reading